Clinical Trial: Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis

Study Status: Available
Recruit Status: Available
Study Type: Expanded Access

Official Title: Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis

Brief Summary: Patients with biopsy proven new world cutaneous or mucocutaneous leishmaniasis will be treated with sodium stibogluconate (Pentostam).

Detailed Summary:
Sponsor: University of California, San Francisco

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of California, San Francisco

Dates:
Date Received: July 27, 2007
Date Started:
Date Completion:
Last Updated: December 12, 2014
Last Verified: December 2014